Hydrocephalus Treatment Articles & Analysis
7 news found
The second-generation ReFlow Mini Flusher breakthrough device is indicated for use in patients living with hydrocephalus or similar conditions like IIH that may be treated with a shunt. ...
This extra fluid puts pressure on the brain and can cause brain damage. Hydrocephalus is characterized by head enlargement in infants. Treatment is often a tube (shunt) inserted surgically into a ventricle of the brain to drain excess fluid, but over time the device can often become dislodged or clogged which then requires more procedures and hospitalizations. ...
The second-generation, FDA-cleared ReFlow Mini Flusher is indicated for use in patients living with hydrocephalus or similar conditions. The reduced size and profile of the technology is designed to better support a broader hydrocephalus patient population, from infants to older adults. ...
Food and Drug Administration (FDA) cleared the ReFlow® System Mini for the treatment of patients with hydrocephalus and other cerebrospinal fluid (CSF) disorders that require shunting. ...
Anuncia Anuncia is a spin-off of Alcyone that wants to develop devices for better treatment of hydrocephalus (the buildup of fluid in the cavities deep within the brain). ...
Anuncia, Inc., a privately-held company focused on better treatment of hydrocephalus and cerebrospinal fluid dysfunctions, announced, today, the successful first-in-human implantation of its Alivio ReFlow™ Ventricular System for treatment of hydrocephalus at Boston Children’s Hospital. ...
Alcyone Lifesciences, Inc., a privately-held company focused on transforming disease modifying therapies for central nervous system (CNS) disorders today announced the separation and spin-off of its Hydrocephalus business. The new company, known as Anuncia, Inc., is an independent company focused on better treatment of Hydrocephalus and ...